These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15572667)

  • 1. p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload.
    Nishida K; Yamaguchi O; Hirotani S; Hikoso S; Higuchi Y; Watanabe T; Takeda T; Osuka S; Morita T; Kondoh G; Uno Y; Kashiwase K; Taniike M; Nakai A; Matsumura Y; Miyazaki J; Sudo T; Hongo K; Kusakari Y; Kurihara S; Chien KR; Takeda J; Hori M; Otsu K
    Mol Cell Biol; 2004 Dec; 24(24):10611-20. PubMed ID: 15572667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The I{kappa}B kinase {beta}/nuclear factor {kappa}B signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression.
    Hikoso S; Yamaguchi O; Nakano Y; Takeda T; Omiya S; Mizote I; Taneike M; Oka T; Tamai T; Oyabu J; Uno Y; Matsumura Y; Nishida K; Suzuki K; Kogo M; Hori M; Otsu K
    Circ Res; 2009 Jul; 105(1):70-9. PubMed ID: 19478205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pressure overload causes cardiac hypertrophy in beta1-adrenergic and beta2-adrenergic receptor double knockout mice.
    Palazzesi S; Musumeci M; Catalano L; Patrizio M; Stati T; Michienzi S; Di Certo MG; Mattei E; Vitelli L; Marano G
    J Hypertens; 2006 Mar; 24(3):563-71. PubMed ID: 16467660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress.
    Donath S; Li P; Willenbockel C; Al-Saadi N; Gross V; Willnow T; Bader M; Martin U; Bauersachs J; Wollert KC; Dietz R; von Harsdorf R;
    Circulation; 2006 Mar; 113(9):1203-12. PubMed ID: 16505176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
    Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
    Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.
    Sun M; Chen M; Dawood F; Zurawska U; Li JY; Parker T; Kassiri Z; Kirshenbaum LA; Arnold M; Khokha R; Liu PP
    Circulation; 2007 Mar; 115(11):1398-407. PubMed ID: 17353445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for p38alpha mitogen-activated protein kinase in embryonic cardiac differentiation.
    Hernández-Torres F; Martínez-Fernández S; Zuluaga S; Nebreda A; Porras A; Aránega AE; Navarro F
    FEBS Lett; 2008 Apr; 582(7):1025-31. PubMed ID: 18314011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of Akt activity by p38alpha MAP kinase in cardiomyocytes involves membrane localization of PP2A through interaction with caveolin-1.
    Zuluaga S; Alvarez-Barrientos A; Gutiérrez-Uzquiza A; Benito M; Nebreda AR; Porras A
    Cell Signal; 2007 Jan; 19(1):62-74. PubMed ID: 16844343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pressure overload induces greater hypertrophy and mortality in female mice with p38alpha MAPK inhibition.
    Liu J; Sadoshima J; Zhai P; Hong C; Yang G; Chen W; Yan L; Wang Y; Vatner SF; Vatner DE
    J Mol Cell Cardiol; 2006 Oct; 41(4):680-8. PubMed ID: 16928383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of p38alpha MAPK in cardiac apoptosis and remodeling after myocardial infarction.
    Ren J; Zhang S; Kovacs A; Wang Y; Muslin AJ
    J Mol Cell Cardiol; 2005 Apr; 38(4):617-23. PubMed ID: 15808838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis.
    Gao XM; Wong G; Wang B; Kiriazis H; Moore XL; Su YD; Dart A; Du XJ
    J Hypertens; 2006 Aug; 24(8):1663-70. PubMed ID: 16877971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted deletion of thioredoxin-interacting protein regulates cardiac dysfunction in response to pressure overload.
    Yoshioka J; Imahashi K; Gabel SA; Chutkow WA; Burds AA; Gannon J; Schulze PC; MacGillivray C; London RE; Murphy E; Lee RT
    Circ Res; 2007 Dec; 101(12):1328-38. PubMed ID: 17916779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of JunD promotes pressure overload-induced apoptosis, hypertrophic growth, and angiogenesis in the heart.
    Hilfiker-Kleiner D; Hilfiker A; Kaminski K; Schaefer A; Park JK; Michel K; Quint A; Yaniv M; Weitzman JB; Drexler H
    Circulation; 2005 Sep; 112(10):1470-7. PubMed ID: 16129800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure.
    Wang J; Xu N; Feng X; Hou N; Zhang J; Cheng X; Chen Y; Zhang Y; Yang X
    Circ Res; 2005 Oct; 97(8):821-8. PubMed ID: 16151019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy.
    Sadoshima J; Montagne O; Wang Q; Yang G; Warden J; Liu J; Takagi G; Karoor V; Hong C; Johnson GL; Vatner DE; Vatner SF
    J Clin Invest; 2002 Jul; 110(2):271-9. PubMed ID: 12122119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability.
    Oka T; Maillet M; Watt AJ; Schwartz RJ; Aronow BJ; Duncan SA; Molkentin JD
    Circ Res; 2006 Mar; 98(6):837-45. PubMed ID: 16514068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats.
    Sheng R; Gu ZL; Xie ML; Zhou WX; Guo CY
    Acta Pharmacol Sin; 2007 Feb; 28(2):191-201. PubMed ID: 17241521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct functions of junD in cardiac hypertrophy and heart failure.
    Ricci R; Eriksson U; Oudit GY; Eferl R; Akhmedov A; Sumara I; Sumara G; Kassiri Z; David JP; Bakiri L; Sasse B; Idarraga MH; Rath M; Kurz D; Theussl HC; Perriard JC; Backx P; Penninger JM; Wagner EF
    Genes Dev; 2005 Jan; 19(2):208-13. PubMed ID: 15655111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological growth synergizes with pathological genes in experimental cardiomyopathy.
    Syed F; Odley A; Hahn HS; Brunskill EW; Lynch RA; Marreez Y; Sanbe A; Robbins J; Dorn GW
    Circ Res; 2004 Dec; 95(12):1200-6. PubMed ID: 15539635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy.
    Jaffré F; Bonnin P; Callebert J; Debbabi H; Setola V; Doly S; Monassier L; Mettauer B; Blaxall BC; Launay JM; Maroteaux L
    Circ Res; 2009 Jan; 104(1):113-23. PubMed ID: 19023134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.